Description
The blend is formulated with precise stoichiometric ratios that maximize each peptide’s bioavailability while minimizing potential side effects. GHK-CU (glycyl-histidyl-lysine copper complex) is renowned for its ability to stimulate collagen production, improve skin elasticity, and promote wound healing through modulation of growth factors. BPC-157 (body protective compound 157) supports gastrointestinal integrity, enhances ligament and tendon repair, and https://brandmoshaver.com/user/makeuprecord08 exerts anti-inflammatory effects by modulating vascular endothelial growth factor pathways. TB-500 (thymosin beta-4) encourages angiogenesis, improves muscle fiber regeneration, and reduces scar tissue formation. KPV (a tripeptide derived from the N-terminal of β-endorphin) offers potent opioid receptor modulation that helps alleviate pain without typical opioid side effects. Together, these peptides provide a multi-faceted approach to tissue repair, anti-inflammatory action, and analgesia.
Product Specifications
- Peptide components: GHK-CU 1 mg, BPC-157 2 mg, TB-500 0.5 mg, KPV 0.3 mg per vial (total 4 mg)
- Concentration: 1 mg/mL in sterile, pyrogen-free solution
- Sterility: GMP-grade production, validated for sterility and endotoxin levels below 0.25 EU/mL
- Packaging: 30 mL single-dose vials with screw-cap and tamper-evident seal
- Shelf life: 24 months when stored at 2–8°C; stable up to 48 hours once reconstituted in sterile water for injection
- Reconstitution: Add 0.9 % saline or bacteriostatic water to achieve desired volume; gentle inversion only, no vortexing
- Administration routes: Subcutaneous, intramuscular, or intravenous (under medical supervision)
- Dosage regimen: Typically 1–2 mg per injection site daily for 7–14 days, followed by tapering as healing progresses
- Compatibility: Non-reactive with common diluents; no known cross-reactivity with other peptide therapies
